Kang T W, Lee M W, Hye M J, Song K D, Lim S, Rhim H, Lim H K, Cha D I
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea.
Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea.
Clin Radiol. 2014 Dec;69(12):1249-58. doi: 10.1016/j.crad.2014.07.012. Epub 2014 Aug 20.
To evaluate the technical feasibility of artificial ascites formation using an angiosheath before percutaneous radiofrequency ablation (RFA) for hepatic tumours and to determine predictive factors affecting the technical failure of artificial ascites formation.
This retrospective study was approved by the institutional review board. One hundred and thirteen patients underwent percutaneous RFA of hepatic tumours after trying to make artificial ascites using an angiosheath to avoid collateral thermal damage. The technical success rate of making artificial ascites using an angiosheath and conversion rate to other techniques after initial failure of making artificial ascites were evaluated. The technical success rate for RFA was assessed. In addition, potential factors associated with technical failure including previous history of transcatheter arterial chemoembolization (TACE) or RFA, type of abdominal surgery, and adjacent perihepatic structures were reviewed. Predictive factors for the technical failure of artificial ascites formation were analysed using multivariate analysis.
The technical success rates of artificial ascites formation by angiosheath and that of RFA were 84.1% (95/113) and 97.3% (110/113), respectively. The conversion rate to other techniques after the failure of artificial ascites formation using an angiosheath was 15.9% (18/113). Previous hepatic resection was the sole independent predictive factor affecting the technical failure of artificial ascites formation (p<0.001, odds ratio = 29.03, 95% confidence interval: 4.56-184.69).
Making artificial ascites for RFA of hepatic tumours using an angiosheath was technically feasible in most cases. However, history of hepatic resection was a significant predictive factor affecting the technical failure of artificial ascites formation.
评估在经皮射频消融(RFA)治疗肝肿瘤前使用血管鞘形成人工腹水的技术可行性,并确定影响人工腹水形成技术失败的预测因素。
本回顾性研究经机构审查委员会批准。113例患者在尝试使用血管鞘制造人工腹水以避免侧支热损伤后接受了肝肿瘤的经皮RFA治疗。评估了使用血管鞘制造人工腹水的技术成功率以及人工腹水初次制造失败后转换为其他技术的转换率。评估了RFA的技术成功率。此外,回顾了与技术失败相关的潜在因素,包括既往经动脉化疗栓塞(TACE)或RFA史、腹部手术类型以及肝周相邻结构。使用多变量分析分析人工腹水形成技术失败的预测因素。
血管鞘制造人工腹水的技术成功率和RFA的技术成功率分别为84.1%(95/113)和97.3%(110/113)。使用血管鞘制造人工腹水失败后转换为其他技术的转换率为15.9%(18/113)。既往肝切除术是影响人工腹水形成技术失败的唯一独立预测因素(p<0.001,比值比=29.03,95%置信区间:4.56-184.69)。
在大多数情况下,使用血管鞘为肝肿瘤RFA制造人工腹水在技术上是可行的。然而,肝切除史是影响人工腹水形成技术失败的重要预测因素。